JP Morgan Private Wealth Advisors’s Neurotrope, Inc. Common NTRP Stock Holding History

JP Morgan Private Wealth Advisors’s Portfolio NTRP Stock Details NTRP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-80,007	Closed	-$642K	–	1504
2019 Q2	$642K	Hold	80,007	–	–	﹤0.01%	896
2019 Q1	$436K	Sell	80,007 -600	-0.7%	-$2.58K	﹤0.01%	1078
2018 Q4	$288K	Buy	80,607 +21,996	+38%	+$133K	﹤0.01%	1187
2018 Q3	$516K	Sell	58,611 -12	-0%	-$115	﹤0.01%	1063
2018 Q2	$567K	Sell	58,623 -301	-0.5%	-$2.77K	﹤0.01%	966
2018 Q1	$480K	Sell	58,924 -1,076	-2%	-$8.54K	﹤0.01%	886
2017 Q4	$422K	Hold	60,000	–	–	﹤0.01%	931
2017 Q3	$310K	Buy	60,000 +30,000	+100%	+$157K	﹤0.01%	1010
2017 Q2	$281K	Buy	30,000 +4,655	+18%	+$49.7K	﹤0.01%	1038
2017 Q1	$484K	Buy	+25,345	New	+$480K	﹤0.01%	871

Other funds holding NTRP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return

OCMI

Oaktop Capital Management II Chatham, New Jersey $1.34B AUM 114.5% 1-Year Est. Return

NRS

Neville Rodie & Shaw New York $1.55B AUM 46.95% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

JP Morgan Private Wealth Advisors's NTRP Position: Q3 2019 in Review

JP Morgan Private Wealth Advisors sold out of Neurotrope, Inc. Common (NTRP) in Q3 2019, closing a stake of 80,007 shares — an estimated $642K sold.

JP Morgan Private Wealth Advisors first reported a position in NTRP in Q1 2017 and held it in 10 quarters. The position peaked at $642K in Q2 2019. 29 funds tracked by Wall St. Rank hold NTRP as of Q3 2019.

JP Morgan Private Wealth Advisors reported no remaining Neurotrope, Inc. Common position as of Q3 2019 after selling out during the quarter.
JP Morgan Private Wealth Advisors sold 80,007 Neurotrope, Inc. Common shares in Q3 2019, an estimated $642K.
JP Morgan Private Wealth Advisors first reported a position in Neurotrope, Inc. Common in Q1 2017 and held it in 10 quarters.
JP Morgan Private Wealth Advisors's Neurotrope, Inc. Common position peaked at $642K in Q2 2019.
29 funds tracked by Wall St. Rank held Neurotrope, Inc. Common as of Q3 2019.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q3 2019, filed 8 Nov 2019.